Research published in the European Journal of Preventive Cardiology reveals that bariatric surgery can reduce cardiac stress and chronic subclinical cardiac injury in morbidly obese patients. In contrast, lifestyle intervention had a limited impact on reducing high-sensitivity cardiac troponin I levels.
Chagas disease is a life-threatening illness caused by the protozoan Trypanosoma cruzi. In Spain, Latin American migrants are at high risk due to mother-to-child transmission, with an estimated 50,000-70,000 people infected. Screening is crucial to detect heart abnormalities early and prevent sudden cardiac death.
Researchers found a strong association between negative news stories about statins and early discontinuation, increasing the risk of heart attacks and cardiovascular mortality. The study suggests that exposure to negative news can play a role in patients' decisions to stop taking their medication.
Patients with coronary artery disease spend an average of eight hours each day sitting despite exercising, according to research published in the European Journal of Cardiovascular Prevention. Women tend to be less sedentary than men, but both have poorer health outcomes when sitting for long periods.
The TATORT-NSTEMI trial found no significant difference in major adverse cardiac events at 12 months between thrombectomy and standard PCI in NSTEMI patients. Thrombus aspiration also did not affect quality of life or functional class.
A recent study found that nearly three-quarters of stroke patients in China have hypertension, with high levels of LDL cholesterol, diabetes, and smoking also prevalent. The research emphasizes the importance of adopting a healthy lifestyle and controlling risk factors to prevent strokes and cardiovascular disease.
Researchers found nearly four in five patients with a specific mutation carried out blackouts, yet only 26% received correct diagnosis and treatment. The study highlights the need for proper medical attention if symptoms occur, as delayed diagnosis can be fatal.
A population-based case-control study found that childhood infections are associated with a three-fold higher occurrence of premature acute coronary syndromes (ACS) later in life. The study suggests that infection may potentiate the impact of traditional risk factors on developing early cardiovascular disease.
A study found that pacemaker checks can identify asymptomatic atrial fibrillation (AF), allowing for early initiation of anticoagulation to prevent strokes. The research involved 223 patients who received a pacemaker and showed that nearly all with undiagnosed AF needed anticoagulation to reduce stroke risk.
Researchers found that sniffing and gasping prevented syncope in patients with vasovagal syncope. The study used a head-up tilt test to mimic standing up quickly, but interrupted the reflex with sniffing or gasping, avoiding falls in blood pressure and heart rate.
A study found that low physical activity was responsible for 17% of cardiovascular deaths in Argentina, with effects greater in women. Engaging in at least 30 minutes of brisk walking 5 days a week may reduce cardiovascular mortality, especially in women and those younger than 70 years old.
A large study found that exercise and stopping smoking had the strongest association with improved depression after a heart attack. Patients who quit smoking had a 2.3 greater chance of improving their depression, while those who were already physically active at the beginning of the study were more likely to improve their symptoms.
A study found that higher concentrations of naturally occurring trans fatty acids were associated with a lower risk of sudden cardiac death and fewer deaths from any cause. Researchers also discovered that low levels of industrially produced trans fatty acids did not pose a health risk, contradicting previous warnings.
The conference will showcase advancements in acute cardiovascular care, including heart attack, cardiac arrest, and pulmonary embolism treatment. Experts will discuss novel therapies and debate controversial topics such as pre-hospital care and bleeding management.
ESC Congress 2015 saw a record-breaking attendance of 32,773 registrations, featuring 28 clinical Hot Line presentations, 18 Clinical Trial Updates, and 20 Registry studies. Key findings included the use of spironolactone for resistant hypertension and its positive implications for clinical practice.
The European Cardiomyopathy Registry Pilot study found that nearly 60% of patients with arrhythmogenic right ventricular cardiomyopathy received implantable cardioverter-defibrillators, a common yet underutilized treatment strategy. Genetic testing was also widely used, with over half of tests yielding positive results.
The VISION Study found that preoperative statin use is linked to a lower risk of cardiovascular complications and mortality after noncardiac surgery. Statins were shown to be associated with a 17% reduction in cardiac complications and a 43% reduction in mortality.
A study in nearly 800,000 patients found a positive association between carbonated beverage consumption and out-of-hospital cardiac arrests of cardiac origin. Limiting carbonated drink consumption may help reduce the risk of fatal cardiovascular disease.
A new study found that treatment with life-saving medications has increased significantly in ischemic heart disease, but levels are still suboptimal. The study also revealed that patients with peripheral artery disease receive fewer recommended medications and have more comorbidities than others.
A study of EUROASPIRE surveys found that smoking prevalence has stayed the same over seven years, but the proportion of smokers with no intention to quit increased. Lifestyle trends have not improved, with high rates of obesity and central obesity reported.
A recent study published in European Heart Journal found that most patients with cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator. The CeRtiTuDe cohort study analyzed data from 1,705 consecutive patients implanted with CRT between 2008 and 2010 in France.
The XANTUS study found that rivaroxaban is safe and effective for stroke prevention in atrial fibrillation patients with low rates of bleeding and stroke. The study confirmed the positive benefit-risk profile of rivaroxaban established in clinical trials, demonstrating its efficacy and tolerability in real-world practice.
A new analysis of the TECOS study adds heart failure data to confirm sitagliptin's cardiovascular safety. The findings provide reassurance to patients and prescribers about the drug's risk profile.
The ELIXA trial demonstrated that lixisenatide, a GLP-1 receptor agonist, did not increase or decrease the rate of cardiovascular events compared to placebo. The study found a modest benefit in weight gain, but also identified patients with heart failure as being at high risk of all-cause death.
A recent study found that depression is strongly associated with the frequency of chest pain in adults with and without underlying coronary artery disease. Patients with depression were three times more likely to experience more frequent chest pain than those without depression.
A gene associated with sudden cardiac death has been identified using implantable cardioverter defibrillator (ICD) monitoring. The GNAS gene polymorphism predicted ventricular tachyarrhythmias and sudden cardiac death in patients from the DISCOVERY trial and Oregon-SUDS study.
Research reveals a four-fold increased risk of in-hospital cardiovascular mortality in AMI patients with respiratory infections. Respiratory infections were associated with longer hospital stays, more severe clinical presentations, and higher incidence of arrhythmias and reinfarction.
A recent study presented at ESC Congress found that young women with diabetes have a six-fold risk of heart attack. The research, which analyzed data from over 7,000 women, also revealed that smoking was the leading risk factor for young women with myocardial infarction.
A sub study of the MR CLEAN trial found that patients with larger thrombi had better neurological recovery after intra arterial treatment. Thrombi size was associated with clinical outcome, and retrieving larger pieces may lead to improved patient results.
A recent study found that adding adenosine triphosphate to pulmonary vein isolation treatment for atrial fibrillation did not significantly reduce late recurrences of the condition. The study, which included 2,113 patients, used ATP to identify and address potential gaps in electrical conduction around the pulmonary veins.
A recent trial published at ESC Congress 2015 found that patient education programs did not significantly impact apixaban adherence. Adherence rates were high across both the control and education groups, with minimal difference observed between the two.
The ALBATROSS study found that mineralocortoid receptor antagonists do not provide a benefit to heart attack patients without heart failure. However, in a subgroup of STEMI patients, MRA treatment may have a potential mortality benefit.
A new trial suggests that pacing may not be effective in preventing cardiac remodeling and improving functional or clinical outcomes in patients with large myocardial infarctions. The study, known as PRomPT, found no significant difference between patients who received pacing and those who did not.
The CIRCUS trial found that cyclosporine did not reduce all-cause death, hospitalization for heart failure, or adverse left ventricular remodelling in STEMI patients undergoing PCI. The study suggested that targeting reperfusion injury remains a major challenge for PCI cardiologists.
The study found that immune cell-mediated thrombotic processes are a realistic target for novel therapies to prevent stent thrombosis. Leukocyte infiltrations were hallmarks of both early and late ST, with neutrophils being the most prominent subset.
Research by Dr. Kristian Kragholm found that bystander CPR was associated with a 30% lower risk of nursing home admission and brain damage in survivors of out-of-hospital cardiac arrest. The study included 2,387 adult survivors who did not have pre-existing conditions or live in a nursing home before the cardiac arrest.
A study of over 17,000 patients found that nearly all survivors were achieved within 35 minutes of CPR, with longer resuscitation efforts offering little benefit. The researchers recommend continuing CPR for at least 35 minutes in out-of-hospital cardiac arrest cases to achieve maximum survival and favorable neurological outcomes.
An 11-year study of over 425,000 patients found that atrial fibrillation's contribution to ischemic stroke risk was negligible in those with multiple comorbidities. The study suggests that stroke prevention should focus on the combined effects of multiple risk factors rather than a single factor.
A small left ventricle with thick walls is the strongest predictor of morphologic remodelling, a first step towards heart failure. This unexpected finding could change risk stratification among patients with stable coronary artery disease.
A study of over 25,000 cardiac arrest patients found that increased AED usage and accompanying initiatives led to higher bystander defibrillation rates in public locations. However, a significant increase was not observed in residential areas, where most out-of-hospital cardiac arrests occur.
Research found higher levels of inflammatory markers in young adults living in polluted cities, indicating a greater risk of heart attack. Long-term air pollution exposure was linked to increased levels of CRP, hsCRP, homocysteine, and fibrinogen.
Patients with atrial fibrillation who received antithrombotic management according to ESC guidelines had better outcomes than those who did not. Guideline-adherent patients had significantly lower rates of major adverse events during one year follow up compared to over- or under-treated patients.
A subgroup analysis of the IMPROVE-IT trial found that ezetimibe significantly reduced the chances of future major cardiac or vascular events in patients with diabetes by 14% compared to placebo. Ezetimibe added to a statin lowered LDL cholesterol at 1 year, resulting in lower risks of cardiovascular events.
The BELIEF study shows that left atrial appendage (LAA) isolation, combined with standard treatment, significantly improves the success rate of catheter ablation for long-standing persistent atrial fibrillation. LAA isolation reduces AF recurrence rates by 30% compared to standard treatment alone.
Research presented at ESC Congress found a strong association between cold weather and severe heart attacks in Winnipeg, Canada. A 6-year study showed that each 10°C drop in temperature increased the risk of ST-elevation myocardial infarction (STEMI) by 7%.
A large-scale study found that cold weather is associated with an increased risk of ischemic stroke in patients with atrial fibrillation. The risk was highest during winter months and lowest in summer, with a 10% increase in risk for every 5°C decrease in daily temperature.
A new algorithm using a highly sensitive troponin I assay can reduce mortality and cut triage times to one hour for patients with suspected acute myocardial infarction. The algorithm allows for safe discharge or rapid treatment initiation, enabling better resource utilization.
Research suggests that exposure to particulate matter and nitrogen dioxide air pollutants is associated with an increased risk of severe heart attacks. The study found that men aged 75 and above were more susceptible to fine particles, while younger individuals were more affected by NO2.
A leadless cardiac pacemaker demonstrated good safety and reliable function in a six-month study. The device effectively captured heart rhythms and had a low rate of serious adverse device effects, suggesting it can be used as an alternative to conventional transvenous pacemakers.
A new study found that antiarrhythmia drug therapy after radiofrequency catheter ablation for atrial fibrillation does not reduce arrhythmia recurrence rates at one year. The treatment, which had shown a temporary benefit in earlier studies, lost its effectiveness once the medication was stopped.